Clinical trial
Erlotinib and Avastin in Patients With Cancer of the Esophagus or…
NCT00442507 · Washington University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00442507 |
|---|---|
| Title | Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction |
| Official title | A Phase II Trial of Erlotinib and Avastin in Previously Treated Patients With Cancer of the Esophagus or Gastroesophageal Junction |
| Acronym | OSI3650 |
| Lead sponsor | Washington University School of Medicine, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Neoplasms, Esophageal Diseases |
| Intervention type | Drug |
| Interventions | Erlotinib, Avastin |
| Enrollment | 6 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Mar 2, 2007 |
| Last update posted | Jul 24, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: